Biochimica et Biophysica Acta: Biomembranes
Издатель: Elsevier · ISSN 0005-2736 · 100 статей
-
From diligence to verification: the emergence of the TechBio-Investor
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Robert Vandersluis
-
The PROTAC milestone: FDA approval of vepdegestrant (ARV-471) for ESR1 -mutated breast cancer
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Xin Lin, Hua Xiang, Guoshun Luo
-
Pharmacological modulation of ATF6: exploiting a stress-integrative node to overcome drug resistance
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Morteza Hassandokht Mashhadi, Mahmoud Aghaei, Saeid Ghavami
-
Precision targeting in prostate cancer: Mechanistic drivers and the evolving clinical pipeline
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Pratiksha Nathe, Yogesh Singh, Pooja Ratre, Swanand Kulkarni
-
Deubiquitinase inhibitors: from evolving concepts to preclinical evaluation
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Gunter Maubach, Lois Hamann, Matthias Stein, Edgar Haak, Michael Naumann
-
Degraders of histone lysine methyltransferases: Progress, challenges, and opportunities
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Mengling Yang, Qiangsheng Zhang, Jing Yang, Ruini Cheng, Xianli Zhou
-
Targeting chemobrain: from experimental models to therapeutic discovery
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Nishant N. Parikh, Hyung-Goo Kim, Amelia Michelle Sojung Moon, Sang Hoon Lee, Sang Hoon Kim, Euiyeon Lee, Mohammad Abdur Rashid, Yongkyu Park,...
-
Outer membrane as a drug target for the treatment of GNB infections
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Urjoshi Chattoraj, Ayesha Fatima, Deepanshi Saxena, Sidharth Chopra
-
Deubiquitinase-targeting chimeras (DUBTACs): a game-changing approach for targeted protein stabilization in drug discovery
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Gebremedhin Solomon Hailu, Emanuele Fabbrizi, Andrea Mancini, Francesco Fiorentino, Antonello Mai, Dante Rotili
-
Model Gateway: Management platform for model-driven drug discovery
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Yan-Shiun Wu, Sai Mahit Vaddadi, Zachary A. Rollins, Nathan A. Morin
-
Small nucleolar RNAs: Emerging therapeutic and diagnostic frontiers in Alzheimer’s disease
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Tripti Sharma, Prince Sharma, Bushra Bashir, Sachin Kumar Singh, Sukriti Vishwas
-
Accelerating pharmaceutical cocrystal discovery via in silico screening: prediction of formation and properties
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Qi Zeng, Yuting Peng, Lixuan Zhang, Minshan Guo, Ting Cai
-
Paediatric Regulation in the European Union: an overview
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Paolo Caferra, Thomas Fraisse, Veronica Baffa, Eva Kalfon, Andrea Salzano, Maria Letizia Trincavelli, Laura Marchetti, Anna Maria Piras
-
mRNA therapeutics for restoring immune tolerance in autoimmune diseases
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Moncef Zouali
-
Artificial intelligence agents and agentic artificial intelligence applied to precision medicine
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Fabricio F. Costa
-
Pharmacological targeting of GCN5/PCAF (KAT2A/B): current drug discovery strategies and translational potential
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Priyanka Pandey, Prajjval Mishra, Pritam Biswas, Sourav Chatterjee, Tapas K. Kundu
-
Artificial intelligence (AI)-enabled platforms for cancer vaccine engineering
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Ajay K. Mali, Sabya Sachi Das, Nanasaheb D. Thorat
-
Integrating population heterogeneity in drug research and early development: a proactive strategy
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Thierry Lavé, Bruno Jolain, Ken Wang, Léa-Isabelle Proulx, Cristina Santini, Juliana Bessa, Valerie Crowell, Patricia Sanwald-Ducray, Ruma...
-
Metabolic reprogramming and drug resistance in hepatocellular carcinoma: The emerging role of SREBP2-driven cholesterol metabolism
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Veerababu Nagati, Swathi Tenugu, Miguel Salazar, Manish K. Tripathi
-
AI-augmented evidence as the next core competence in rare disease drug development: from snapshots to 360-degree movies
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Ning Lu
-
The platform technology approach in the EU regulation of medicines for human use: stakeholder perspectives on its definition and implementation
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Stephanie M.P. Oskam, Lourens T. Bloem, Marcel H.N. Hoefnagel, Falk Ehmann, Mike Broeders, Anna M.G. Pasmooij
-
Biochemical aspects of chromatin-modifying drugs
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Meran Keshawa Ediriweera, Sharmila Jayasena
-
Can agentic AI dent Eroom’s Law? Large reasoning models across the drug discovery and development pipeline
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Sheraz Khan, John G. Samuelsson, Xuemei Cai, Kannan Natarajan, Subha Madhavan
-
Covalent small-molecule RNA targeting in Alzheimer’s disease: Computational strategies, challenges and opportunities
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Vanktesh Kumar, Stalin Arulsamy, Shivank Sharma, Shubham Kumar, Violina Kakoty
-
Universal care under strain: navigating population ageing in Europe
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Charles H. Jones, Marie Beitelshees, Mikael Dolsten
-
Interplay between RNA m 6 A modification and transglutaminase 2 inhibitor effects on mitophagy dysfunction in Alzheimer’s disease
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Ankita Chatterjee, Thakur Gurjeet Singh, Shareen Singh, Amritpal Kaur, Sukriti Vishwas
-
Toward sustainable therapeutics: integrating regenerative medicine into pharmacological sustainability frameworks
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Diego Delgado, Unax Lertxundi, Laura Brizuela, Gorka Orive, Mikel Sánchez
-
Single-cell and spatial transcriptomic insights into fibrotic mechanisms and therapeutic opportunities
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Jia Mi, Kaixin Su, Rifu Wang, Jian Zhou, Fei Yan, Ousheng Liu
-
Tumor hypoxia: Molecular pathways and therapeutic interventions
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Jie-Ning Li, Ching-Hung Lin, Ming-Yang Wang, Pai-Sheng Chen
-
Reassessing R&D outcomes of leading pharmaceutical companies
Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Alexander Schuhmacher, Michael Witting, Dominik Hartl, Markus Hinder, Oliver Gassmann